Antibiotic Usage for Treatment of Acute Upper Respiratory Tract Infections in Children in Lithuania from 2018 to 2022

Tadas Alčauskas1, Kristina Garuolienė2, Sigita Burokienė3

  • 1Faculty of Medicine, Vilnius University, M. K. Ciurlionio 21, LT-03101 Vilnius, Lithuania.

PubMed

Insights

Antibiotic prescriptions for children's upper respiratory tract infections (URIs) in Lithuania decreased overall but saw a relative increase in penicillin use. Prescribing practices did not align with national guidelines for rational antibiotic therapy.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute upper respiratory tract infections (URIs) are common in children.
  • Rational antibiotic therapy is crucial for combating antimicrobial resistance.
  • Antibiotic prescribing for URIs is a significant public health concern.

Purpose of the Study:

  • To evaluate antibiotic prescribing practices for Lithuanian children with URIs from 2018 to 2022.
  • To identify trends in antibiotic use, specific drug classes, and adherence to national guidelines.
  • To analyze the impact of prescribing patterns on antimicrobial resistance.

Main Methods:

  • Observational study utilizing secondary data from the Lithuanian Compulsory Health Insurance Fund (CHIF) electronic records.
  • Analysis of antibiotic prescriptions for children aged 0-18 years diagnosed with URIs between January 2018 and December 2022.
  • Categorization of antibiotics using the Anatomical Therapeutic Chemical (ATC) Classification system (J01 group).

Main Results:

  • Over 445,000 antibiotic prescriptions for URIs were issued to children (0-18 years) between 2018-2022.
  • Children aged 0-5 years accounted for 51.70% of these prescriptions.
  • Penicillins (amoxicillin) were most common for nasopharyngitis, macrolides (clarithromycin) for laryngitis/tracheitis, and cefadroxil for cephalosporins.

Conclusions:

  • While overall URI antibiotic prescriptions decreased, penicillin use relatively increased.
  • Acute tonsillitis and pharyngitis were the most frequent diagnoses, primarily in young children.
  • Prescribing practices during 2018-2022 did not meet Lithuania's National Recommendations for Rational Antibiotic Use.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...